Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Soligenix Inc (SNGX)

Soligenix Inc (SNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing ACCESSWIRE - Tue Dec 3, 9:45AM CST

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit...

IMRN : 1.9600 (-1.75%)
ULY : 0.5030 (-4.14%)
IMUX : 1.0000 (-3.85%)
NMTC : 0.7582 (+0.03%)
SNGX : 2.95 (-4.22%)
TMG.VN : 0.190 (unch)
BLGO : 0.1950 (+8.64%)
FET : 14.21 (-1.80%)
ACFN : 18.0000 (-0.55%)
NRBO : 2.36 (+0.43%)
TGCB : 0.0800 (-15.79%)
SOTK : 4.23 (-4.73%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 ACCESSWIRE - Wed Nov 27, 1:00AM CST

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

THAR : 2.07 (-1.43%)
ACXP : 0.8250 (+8.77%)
UBI.AX : 0.110 (-12.00%)
GRF.VN : 0.480 (-4.00%)
WISA : 1.7000 (-1.16%)
NNVC : 1.4900 (+2.76%)
ALCO : 26.17 (+3.60%)
MYPS : 2.12 (+8.72%)
ABL : 7.72 (+2.80%)
PERF : 2.22 (+1.83%)
PETV : 0.4500 (+0.45%)
ABEO : 5.70 (+1.24%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 ACCESSWIRE - Wed Nov 27, 1:00AM CST

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

ESGH.TO : 29.84 (-0.23%)
THAR : 2.07 (-1.43%)
ACXP : 0.8250 (+8.77%)
GRF.VN : 0.480 (-4.00%)
WISA : 1.7000 (-1.16%)
ALCO : 26.17 (+3.60%)
NNVC : 1.4900 (+2.76%)
ABL : 7.72 (+2.80%)
MYPS : 2.12 (+8.72%)
PERF : 2.22 (+1.83%)
PETV : 0.4500 (+0.45%)
ABEO : 5.70 (+1.24%)
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference GlobeNewswire - Thu Oct 24, 6:30AM CDT

SNGX : 2.95 (-4.22%)
Soligenix to Present at The ThinkEquity Conference PR Newswire - Mon Oct 16, 2023

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SNGX : 2.95 (-4.22%)
Soligenix Announces Achievement of Two-Year Stability with Bivalent and Trivalent Thermostabilized Filovirus Vaccines when Stored at High Temperatures PR Newswire - Mon Sep 25, 2023

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SNGX : 2.95 (-4.22%)
Soligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting and Additional Proposal to be Considered by Stockholders PR Newswire - Fri Sep 22, 2023

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SNGX : 2.95 (-4.22%)
Soligenix Announces Recent Accomplishments And Second Quarter 2023 Financial Results PR Newswire - Mon Aug 21, 2023

/PRNewswire/ -- Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SNGX : 2.95 (-4.22%)
HyBryte™ Expanded Treatment Trial in Cutaneous T-Cell Lymphoma Opens Enrollment PR Newswire - Thu Aug 10, 2023

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SNGX : 2.95 (-4.22%)
Soligenix Announces Expansion of SGX302 (Synthetic Hypericin) Phase 2a Study in Mild-to-Moderate Psoriasis PR Newswire - Tue Jul 11, 2023

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

SNGX : 2.95 (-4.22%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot